The SUMMIT Study: A Cancer Screening Study

Active, not recruitingOBSERVATIONAL
Enrollment

13,035

Participants

Timeline

Start Date

April 8, 2019

Primary Completion Date

May 31, 2025

Study Completion Date

August 31, 2030

Conditions
CancerLung Cancer
Interventions
RADIATION

Low Dose CT scan

Low Dose chest CT scan conferring an equivalent radiation dose of less than 2 mSv to the average size patient. The study aims to keep most scans under 1 mSv (ultra-low dose), and all scans under 2 mSv.

Trial Locations (1)

Unknown

UCLH, London

All Listed Sponsors
collaborator

GRAIL, Inc.

INDUSTRY

collaborator

University College London Hospitals

OTHER

lead

University College, London

OTHER

NCT03934866 - The SUMMIT Study: A Cancer Screening Study | Biotech Hunter | Biotech Hunter